The Devices and Advanced Therapies theme was developed in line with the UK government’s Life Sciences Vision 2021, which aims to fast-track patient access to new treatments and technologies.
This is an exciting new theme driven by the need to support the rapid advancements in Medical Devices and Advanced Therapy research in Cambridge.
The term ‘medical device’ includes a broad range of products that are used in healthcare. They can be physical items (such as a blood pressure monitor) or software (such as a healthcare app on your phone) which are used for the diagnosis, prevention, monitoring or treatment of illness or disability.
The term ‘advanced therapies’ covers medicinal products that are either gene therapies, cell therapies or tissue-engineered therapies. These are designed to treat underlying conditions.
Our clinicians and researchers have the world-leading expertise to develop new devices and therapies, and this theme will facilitate and accelerate the pathway from small-scale lab-based developments through to providing benefit for patients in clinical practice.
We will use the NIHR/MRC Framework for developing and evaluating complex interventions to support these pathways.
We have a ‘One Stop Shop’ to support and coordinate the pipeline from idea to proof of concept, real-world testing, adoption and roll-out in the NHS. This figure shows our network of resources to support development pathways.
Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes
Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial
Multicentre clinical evaluation of the safety and performance of a simple transperineal access system for prostate biopsies for suspected prostate cancer: The CAMbridge PROstate Biopsy DevicE (CamPROBE) study